These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27404516)
1. Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial. Zheng JS; Lin M; Imamura F; Cai W; Wang L; Feng JP; Ruan Y; Tang J; Wang F; Yang H; Li D Sci Rep; 2016 Jul; 6():29522. PubMed ID: 27404516 [TBL] [Abstract][Full Text] [Related]
2. Changes of urine metabolites in response to n-3 fatty acid supplements and their correlation with metabolic risk factors in patients with type 2 diabetes. Ruan Y; Zheng J; Ren Y; Tang J; Li J; Li D Food Funct; 2019 May; 10(5):2471-2479. PubMed ID: 30977496 [TBL] [Abstract][Full Text] [Related]
3. Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial. Zheng JS; Lin M; Fang L; Yu Y; Yuan L; Jin Y; Feng J; Wang L; Yang H; Chen W; Li D; Tang J; Cai W; Shi M; Li Z; Wang F; Li D Mol Nutr Food Res; 2016 Oct; 60(10):2176-2184. PubMed ID: 27279274 [TBL] [Abstract][Full Text] [Related]
4. Pure omega 3 polyunsaturated fatty acids (EPA, DPA or DHA) are associated with increased plasma levels of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) in a short-term study in women. Liu G; Gibson RA; Callahan D; Guo XF; Li D; Sinclair AJ Food Funct; 2020 Mar; 11(3):2058-2066. PubMed ID: 32142084 [TBL] [Abstract][Full Text] [Related]
5. Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial. Wang F; Wang Y; Zhu Y; Liu X; Xia H; Yang X; Sun G Eur J Nutr; 2017 Oct; 56(7):2415-2422. PubMed ID: 27913872 [TBL] [Abstract][Full Text] [Related]
6. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals. Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682 [TBL] [Abstract][Full Text] [Related]
7. Flaxseed oil intake reduces serum small dense low-density lipoprotein concentrations in Japanese men: a randomized, double blind, crossover study. Kawakami Y; Yamanaka-Okumura H; Naniwa-Kuroki Y; Sakuma M; Taketani Y; Takeda E Nutr J; 2015 Apr; 14():39. PubMed ID: 25896182 [TBL] [Abstract][Full Text] [Related]
8. The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population. Lee TC; Ivester P; Hester AG; Sergeant S; Case LD; Morgan T; Kouba EO; Chilton FH Lipids Health Dis; 2014 Dec; 13():196. PubMed ID: 25515553 [TBL] [Abstract][Full Text] [Related]
9. CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome. Lankinen MA; Hanhineva K; Kolehmainen M; Lehtonen M; Auriola S; Mykkänen H; Poutanen K; Schwab U; Uusitupa M PLoS One; 2015; 10(4):e0124379. PubMed ID: 25874636 [TBL] [Abstract][Full Text] [Related]
10. Effect of supplementation with flaxseed oil and different doses of fish oil for 2 weeks on plasma phosphatidylcholine fatty acids in young women. Hodson L; Crowe FL; McLachlan KJ; Skeaff CM Eur J Clin Nutr; 2018 Jun; 72(6):832-840. PubMed ID: 29849178 [TBL] [Abstract][Full Text] [Related]
11. Effects of marine-derived and plant-derived omega-3 polyunsaturated fatty acids on erythrocyte fatty acid composition in type 2 diabetic patients. Liu H; Wang F; Liu X; Xie Y; Xia H; Wang S; Sun G Lipids Health Dis; 2022 Feb; 21(1):20. PubMed ID: 35144649 [TBL] [Abstract][Full Text] [Related]
12. Dietary fish oil supplementation affects serum fatty acid concentrations in horses. O'Connor CI; Lawrence LM; Hayes SH J Anim Sci; 2007 Sep; 85(9):2183-9. PubMed ID: 17504965 [TBL] [Abstract][Full Text] [Related]
13. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Young GS; Conquer JA; Thomas R Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207 [TBL] [Abstract][Full Text] [Related]
14. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Ramprasath VR; Eyal I; Zchut S; Jones PJ Lipids Health Dis; 2013 Dec; 12():178. PubMed ID: 24304605 [TBL] [Abstract][Full Text] [Related]
15. Lipid extract from blue mussel (Mytilus edulis) improves glycemic traits in Chinese type 2 diabetic mellitus patients: a double-blind randomized controlled trial. Kuang X; Shao X; Li H; Jiang D; Gao T; Yang J; Li K; Li D J Sci Food Agric; 2023 Apr; 103(6):2970-2980. PubMed ID: 36409163 [TBL] [Abstract][Full Text] [Related]
16. Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial. Yang B; Shi L; Wang AM; Shi MQ; Li ZH; Zhao F; Guo XJ; Li D J Agric Food Chem; 2019 Jan; 67(1):184-192. PubMed ID: 30511840 [TBL] [Abstract][Full Text] [Related]
17. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Berstad P; Seljeflot I; Veierød MB; Hjerkinn EM; Arnesen H; Pedersen JI Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. McManus RM; Jumpson J; Finegood DT; Clandinin MT; Ryan EA Diabetes Care; 1996 May; 19(5):463-7. PubMed ID: 8732710 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers of food intake and nutrient status are associated with glucose tolerance status and development of type 2 diabetes in older Swedish women. Savolainen O; Lind MV; Bergström G; Fagerberg B; Sandberg AS; Ross A Am J Clin Nutr; 2017 Nov; 106(5):1302-1310. PubMed ID: 28903960 [No Abstract] [Full Text] [Related]
20. Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes, but not chronic kidney disease: a longitudinal population-based cohort study. Miao Z; Zeng FF; Tian Y; Xiao C; Yan Y; Jiang Z; Fu Y; Chen YM; Zheng JS Am J Clin Nutr; 2023 Sep; 118(3):637-645. PubMed ID: 37482300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]